Steward Partners Investment Advisory, LLC

Position in OTLK — Outlook Therapeutics, Inc.

CIK 1723397 STAMFORD, CT

Position in OTLK

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

-$20 QoQ

Shares Held

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#53

of 54 holders

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Steward Partners Investment Advisory, LLC holds $46,353,076 across 170 Biotechnology names. OTLK ranks #167 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VKTX	Viking Therapeutics, Inc.	338,246	$11,006,524
2	VRTX	Vertex Pharmaceuticals Inc / Ma	17,863	$7,976,544
3	ARGX	Argenx SE	9,371	$6,843,172
4	REGN	Regeneron Pharmaceuticals, Inc.	4,620	$3,569,596
5	BMRN	Biomarin Pharmaceutical Inc	35,027	$1,978,675
6	CRMD	CorMedix Inc.	229,465	$1,558,067
7	SPRY	ARS Pharmaceuticals, Inc.	146,453	$1,176,017
8	NKTR	Nektar Therapeutics	15,526	$1,117,095

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2	14	0.0%	Shares	Sole	2026-05-08
2025-12-31	$22	14	0.0%	Shares	Sole	2026-02-12
2025-09-30	$14	14	-100.0%	Shares	Sole	2025-11-12
2025-06-30	$585,921	366,201	0.0%	Shares	Sole	2025-08-12
2025-03-31	$446,765	366,201	+2615621.4%	Shares	Sole	2025-05-13
2024-12-31	$26	14	0.0%	Shares	Sole	2025-02-06
2024-09-30	$74	14	0.0%	Shares	Sole	2024-11-14
2024-06-30	$103	14	0.0%	Shares	Sole	2024-08-08
2024-03-31	$167	14	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.